AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Palbo 75mg Capsule

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Palbociclib (75mg)

Overview Palbo 75mg Capsule

Estrogen receptor-positive, HER2-negative metastatic breast cancer is treated with the 75mg Palbo capsule, administered concurrently with hormonal therapies. Consistent daily intake, ideally with food, at the same time, maximizes efficacy. Dosage and frequency are determined individually by your physician, based on your specific condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper use or overdose can lead to severe adverse reactions. Therapeutic benefits might not be immediately apparent; discontinue use only under your doctor's guidance. Common side effects encompass fatigue, alopecia, dermatological reactions, emesis, and diarrhea. Myelosuppression, potentially increasing infection risk, is a possibility; report any signs of infection (fever, chills, weakness), bleeding, or dizziness promptly. Pre-existing cardiac, hepatic, or renal conditions, and concurrent medication use, particularly anti-infectives, must be disclosed to your physician. Significant drug interactions are possible; inform your healthcare provider of all medications you are currently taking. Palbo is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout treatment.

Uses of Palbo 75mg Capsule

Malignant breast tumor

Major Benefits of Palbo 75mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Palbo 75mg Capsules with food.

Common Side effects of Palbo 75mg Capsule:

  • Decreased blood cells (red cells, white cells, and platelets)
  • Fatigue
  • Hair loss
  • Rash
  • Vomiting
  • Diarrhea
  • Nausea
  • Decreased appetite
  • Infection
  • Decreased white blood cell count
  • Stomatitis (Inflammation of the mouth)
  • Anemia (low number of red blood cells)
  • Weakness
  • Fever

How to use Palbo 75mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Palbo 75mg Capsules with food.

How Palbo 75mg Capsule works:

Palbociclib 75mg capsules are used in cancer treatment. Their mechanism involves blocking cyclin-dependent kinases 4 and 6, crucial proteins driving cell growth. By inhibiting these kinases, the drug halts the uncontrolled replication of cancer cells. Specifically, it's effective against estrogen receptor-positive breast cancers by interfering with their cell cycle progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Palbo 75mg Capsules may pose unknown safety risks. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Palbo 75mg capsules during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Palbo 75mg capsules are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Driving ability may be impaired by Palbo 75mg Capsules, as they can induce tiredness in certain individuals. Therefore, operate machinery or vehicles with care if experiencing this effect.

KidneyKidneySAFE IF PRESCRIBED

Palbo 75mg capsules can be administered to patients with kidney disease without modification to the prescribed dosage.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise prudence when using Palbo 75mg capsules. Dosage modification of Palbo 75mg capsules may be necessary. Physician consultation is advised.

What if you forget to take Palbo 75mg Capsule :

NA

Facts to Know About Palbo 75mg Capsule

LabelValue
Type of Compound Piperazine-pyridinyl derivatives
Addictive None.
Medication Classification Cancer-fighting medications
Mechanism of Action CDK inhibitor

FAQs on Palbo 75mg Capsule

75mg Palbo capsules are an anti-neoplastic medication. Their mechanism of action involves the inhibition of cyclin-dependent kinase inhibitor proteins. This inhibition reduces cancer cell proliferation and retards disease advancement.
Treatment length differs individually. Your physician will determine the necessary treatment course based on your health status, treatment response, and tolerability of any adverse effects. Dosage reduction or temporary/permanent treatment cessation may occur if specific side effects arise.
The majority of side effects associated with this medication are temporary and resolve upon discontinuation. A known adverse reaction to Palbo 75mg Capsule is neutropenia, a decrease in white blood cells leading to immune system compromise. Consequently, infection risk increases during treatment. This effect, however, typically subsides quickly following cessation of Palbo 75mg Capsule.
Blood tests are crucial because this medication may reduce your blood cell levels. These routine tests monitor Palbo 75mg Capsule's impact on your white blood cells, red blood cells, and platelets. Testing is scheduled for the start of every chemotherapy cycle, day 15 of the initial two cycles, and as medically necessary.
Palbo 75mg capsules are typically administered once daily for three weeks, followed by a one-week treatment-free period, completing a full 28-day cycle. Consume the medication with food at the same time each day. Capsules should be swallowed whole; do not break, crush, or chew them. Discard any damaged capsules. If vomiting occurs after ingestion, refrain from taking a repeat dose and resume the prescribed schedule.
Women capable of becoming pregnant taking Palbo 75mg Capsules, and their partners, must employ effective contraception (for example, a dual-barrier approach like condoms and diaphragms). This contraceptive practice should continue throughout treatment and for a minimum of three weeks post-treatment for women. Male recipients of Palbo 75mg Capsules should utilize birth control measures for at least fourteen weeks following treatment cessation.
Treatment with Palbo 75mg Capsules may impact male reproductive capacity. Therefore, men undergoing this treatment should explore sperm banking options beforehand.
Palbo 75mg Capsule can cause severe adverse reactions such as breathlessness, lightheadedness, fatigue, and abnormal bleeding (including bruising and epistaxis). Fever, shivering, infection indicators, and a rapid, erratic, or forceful pulse are also possible. Seek immediate medical attention or contact your physician if any of these occur.
Palbo 75mg Capsule
4,925
MRP 6,000
17% off